Yoshiki Tsuboi1, Hiroya Yamada2, Eiji Munetsuna3, Mirai Yamazaki4, Genki Mizuno4, Yuri Murase4, Koji Ohashi4, Hiroaki Ishikawa4, Mari Kondo1, Takashi Inoue1,5, Shuji Hashimoto2, Nobuyuki Hamajima6, Koji Suzuki1,5. 1. Clinical Laboratory Medicine, Fujita Health University Graduate School of Health Sciences. 2. Department of Hygiene, Fujita Health University School of Medicine. 3. Department of Biochemistry, Fujita Health University School of Medicine. 4. Department of Clinical Biochemistry, Fujita Health University School of Health Sciences. 5. Department of Preventive Medical Sciences, Fujita Health University School of Health Sciences. 6. Department of Healthcare Administration, Nagoya University Graduate School of Medicine.
Abstract
AIM: Aberrant global DNA methylation is involved in the development of several diseases, including cardiovascular disease (CVD). We investigated whether the methylation of long interspersed nuclear element-1 (LINE-1) in leukocytes is associated with dyslipidemia, a major risk factor for CVD, in the Japanese general population. METHODS: We conducted a cross-sectional study consisting of 420 Japanese subjects (187 men and 233 women) without a clinical history of cancer, stroke, or ischemic heart disease. LINE-1 DNA methylation levels in leukocytes were measured using a pyrosequencing method. RESULTS: Significantly higher odds ratios (ORs) for hypermethylation were observed in the high LDL cholesterol and high LDL/HDL ratio groups than the corresponding normal group (high LDLC group: OR, 1.88; 95% confidence interval [CI], 1.20-2.96, high LDL/HDL ratio group: OR, 1.90; 95% CI, 1.20-3.01). Subjects with 2 or more lipid abnormalities had significantly higher ORs for hypermethylation than those with no lipid abnormality (OR, 2.31; 95% CI, 1.11-4.82). CONCLUSION: LINE-1 DNA hypermethylation in leukocytes was associated with CVD risk profiles: high LDLC, high LDL/HDL ratio, and the degree of abnormal lipid metabolism.
AIM: Aberrant global DNA methylation is involved in the development of several diseases, including cardiovascular disease (CVD). We investigated whether the methylation of long interspersed nuclear element-1 (LINE-1) in leukocytes is associated with dyslipidemia, a major risk factor for CVD, in the Japanese general population. METHODS: We conducted a cross-sectional study consisting of 420 Japanese subjects (187 men and 233 women) without a clinical history of cancer, stroke, or ischemic heart disease. LINE-1 DNA methylation levels in leukocytes were measured using a pyrosequencing method. RESULTS: Significantly higher odds ratios (ORs) for hypermethylation were observed in the high LDL cholesterol and high LDL/HDL ratio groups than the corresponding normal group (high LDLC group: OR, 1.88; 95% confidence interval [CI], 1.20-2.96, high LDL/HDL ratio group: OR, 1.90; 95% CI, 1.20-3.01). Subjects with 2 or more lipid abnormalities had significantly higher ORs for hypermethylation than those with no lipid abnormality (OR, 2.31; 95% CI, 1.11-4.82). CONCLUSION: LINE-1 DNA hypermethylation in leukocytes was associated with CVD risk profiles: high LDLC, high LDL/HDL ratio, and the degree of abnormal lipid metabolism.
Entities:
Keywords:
Cross-sectional study; Dyslipidemia; Epigenetics; Global DNA methylation; LINE-1
Authors: Zhong-Zheng Zhu; Lifang Hou; Valentina Bollati; Letizia Tarantini; Barbara Marinelli; Laura Cantone; Allen S Yang; Pantel Vokonas; Jolanta Lissowska; Silvia Fustinoni; Angela C Pesatori; Matteo Bonzini; Pietro Apostoli; Giovanni Costa; Pier Alberto Bertazzi; Wong-Ho Chow; Joel Schwartz; Andrea Baccarelli Journal: Int J Epidemiol Date: 2010-09-15 Impact factor: 7.196
Authors: Mikko O Hiltunen; Mikko P Turunen; Tomi P Häkkinen; Juha Rutanen; Maria Hedman; Kimmo Mäkinen; Anna-Mari Turunen; Katriina Aalto-Setälä; Seppo Ylä-Herttuala Journal: Vasc Med Date: 2002-02 Impact factor: 3.239
Authors: W Perng; E Villamor; M R Shroff; J A Nettleton; J R Pilsner; Y Liu; A V Diez-Roux Journal: Nutr Metab Cardiovasc Dis Date: 2013-12-25 Impact factor: 4.222
Authors: Ljiljana Stojković; Manja Zec; Maja Zivkovic; Maja Bundalo; Maja Bošković; Marija Glibetić; Aleksandra Stankovic Journal: Front Nutr Date: 2021-06-17